TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10826461

Group type: EXPERIMENTAL
Intervention: PPR (physiological pattern release) verapamil hydrochloride
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Amlodipine besylate
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Amlodipine-atenolol combination
Number of subjects: 1032

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: PPR verapamil
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (gastrointestinal system)
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Symptom distress
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Symptom distress change (1 step)
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Extreme change in symptom distress
Number of subjects: 1032
Study: 8701624

Group type: EXPERIMENTAL
Intervention: 2 g cefotiam
Number of subjects: 97

Group type: COMPARATOR
Intervention: 1200 mg clindamycin
Number of subjects: 97
Study: 25025189

Group type: EXPERIMENTAL
Intervention: Hydrotherapy treatment (three individual sessions each week for four weeks)
Number of subjects: 20
Study: 6347743

Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 31082897

Group type: EXPERIMENTAL
Intervention: Low ligation of inferior mesenteric artery (LL)
Number of subjects: 214

Group type: COMPARATOR
Intervention: High ligation of inferior mesenteric artery (HL)
Number of subjects: 214
Study: 27727066

Group type: COMPARATOR
Intervention: CIS (radiation-cisplatin without cetuximab)
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: CET/CIS (radiation-cisplatin with cetuximab)
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: p16-positive OPC patients
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: Higher pretreatment PSS-HN diet, PSS-HN eating, FACT-HN, and EQ-5D index scores
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: Higher baseline FACT-HN total, functional, physical subscale, and EQ-5D index scores
Number of subjects: 818
Study: 27220601

Group type: EXPERIMENTAL
Intervention: Rutin-containing cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control cream
Number of subjects: 40
Study: 24731895

Group type: EXPERIMENTAL
Intervention: Qigong training (practiced three times per week for six months)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control group (usual routine care)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Qigong training
Number of subjects: 172
Study: 22658702

Group type: EXPERIMENTAL
Intervention: Methylphenidate (1 mg/kg per day) for 90 days
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 35
Study: 20870668

Group type: COMPARATOR
Intervention: CPAP 2 cm H2O (CPAP2; n=25)
Number of subjects: 75

Group type: COMPARATOR
Intervention: CPAP 5 cm H2O (CPAP5; n=25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: HFPPV (n=25)
Number of subjects: 75
Study: 17434245

Group type: EXPERIMENTAL
Intervention: Maximum Step Length
Number of subjects: 21
Study: 15377651

Group type: EXPERIMENTAL
Intervention: Intravenous adenosine (10 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Intravenous adenosine (10 mg) during hyperoxia
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 16374480

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (untreated arms)
Number of subjects: 40
Study: 10918923

Group type: EXPERIMENTAL
Intervention: Indinavir liquid (80 mL, 10 mg/mL)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Indinavir capsules (800 mg as two 400-mg capsules)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Indinavir liquid and capsules
Number of subjects: 12
Study: 8895623

Group type: EXPERIMENTAL
Intervention: Preoperative flexion less than 90 degrees
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Preoperative flexion 91 to 105 degrees
Number of subjects: 621

Group type: COMPARATOR
Intervention: Preoperative flexion greater than 105 degrees
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Preoperative knee score less than 27
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Preoperative knee score 28 to 40
Number of subjects: 621

Group type: COMPARATOR
Intervention: Preoperative knee score greater than 40
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Preoperative functional score less than 40
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: Preoperative functional score 41 to 50
Number of subjects: 621

Group type: COMPARATOR
Intervention: Preoperative functional score greater than 50
Number of subjects: 621
Study: 2049240

Group type: EXPERIMENTAL
Intervention: Sulindac 200 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 6303553

Group type: EXPERIMENTAL
Intervention: Misonidazole 1.200 mg/m2 orally on each treatment day
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Misonidazole
Number of subjects: 67
Study: 30575426

Group type: EXPERIMENTAL
Intervention: Canagliflozin (from CANVAS trial)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Empagliflozin (from EMPA-REG trial)
Number of subjects: 0
Study: 30656169

Group type: EXPERIMENTAL
Intervention: Stability exercise (SE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Balance exercise (BE)
Number of subjects: 30
Study: 27866658

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) with modulated electrohyperthermia (mEHT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oral transmucosal fentanyl citrate (OTFC)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Modulated electrohyperthermia (mEHT)
Number of subjects: 12
Study: 24580023

Group type: EXPERIMENTAL
Intervention: Clobazam
Number of subjects: 267
Study: 22650145

Group type: EXPERIMENTAL
Intervention: Acupoint injection using cervical Jiaji (EX‐B 2), Fengchi (GB 20), Ashi points, etc. with medications including simple Chinese herbs (Danggui injection, etc.), compound Chinese herbs (compound Danggui injection, etc.), simple western medicine (vitamin B family, etc.), and Chinese herbs combined with western medicine (compound Danggui injection combined with vitamin B12, etc.)
Number of subjects: 0
Study: 20606481

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 200 mg orally thrice a day for 3 months
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control group (not receiving NAC)
Number of subjects: 325
Study: 18001211

Group type: EXPERIMENTAL
Intervention: 80 mg purified isoflavones administered in 2 divided doses of 40 mg for 12 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 15683483

Group type: EXPERIMENTAL
Intervention: Triggered biatrial pacing (BIP-AAT; n = 50)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Single right atrial pacing (RAP-AAI; n = 22)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Triggered biatrial pacing (BIP-AAT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Single right atrial pacing (RAP-AAI)
Number of subjects: 72
Study: 11858482

Group type: EXPERIMENTAL
Intervention: s.c. melagatran (1, 2 or 4 mg bid) for 2 days followed by oral ximelagatran (6, 12 or 24 mg bid) for 6-9 days
Number of subjects: 136

Group type: COMPARATOR
Intervention: dalteparin 5000 IU s.c. once daily for 8-11 days
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: s.c. melagatran plus oral ximelagatran
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: ximelagatran and melagatran
Number of subjects: 136
Study: 10421921

Group type: EXPERIMENTAL
Intervention: Regional anesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 30
Study: 7559370

Group type: EXPERIMENTAL
Intervention: Venlafaxine (average dosage of approximately 350 mg/day during Weeks 2 to 4)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 31412937

Group type: EXPERIMENTAL
Intervention: Peek Community Eye Health system (Peek CEH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current care (periodic health centre‐based outreach clinics)
Number of subjects: 0
Study: 28786523

Group type: EXPERIMENTAL
Intervention: Sevelamer 3200 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: CCK (0.4 pmol sulfated CCK-8/kg/min)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 15
Study: 26452769

Group type: EXPERIMENTAL
Intervention: Processes of Change (Self-Liberation)
Number of subjects: 2718

Group type: EXPERIMENTAL
Intervention: Processes of Change (Reinforcement Management)
Number of subjects: 2718

Group type: EXPERIMENTAL
Intervention: Overall use of Processes of Change
Number of subjects: 2718
Study: 25268516

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg once daily for a maximum of 28 days
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study: 21959675

Group type: EXPERIMENTAL
Intervention: Tango dancing program (twice weekly for 12 months)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Tango dancing program
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 19733053

Group type: EXPERIMENTAL
Intervention: 2% lidocaine/epinephrine/fentanyl mixture
Number of subjects: 100

Group type: COMPARATOR
Intervention: 0.5% levobupivacaine
Number of subjects: 100
Study: 17324398

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg at weeks 0, 2, and 6, followed by maintenance therapy every 8 weeks
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg every 8 weeks
Number of subjects: 112

Group type: COMPARATOR
Intervention: Infliximab 5 mg/kg every 12 weeks
Number of subjects: 112
Study: 15466674

Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLU)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Comprehensive Cognitive Behavioral Therapy (CCBT)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: CCBT/Fluoxetine (CCBT/FLU)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: CCBT/Placebo (CCBT/PBO)
Number of subjects: 295

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: CCBT
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Fluoxetine (FLU) and CCBT/FLU
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: All active treatments
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Combined treatment (CCBT/FLU)
Number of subjects: 295
Study: 11799259

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-a) administered at a dosage of 3 million units three times weekly for 1 year
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no IFN-a treatment)
Number of subjects: 30
Study: 9723642

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 0
Study: 7989854

Group type: EXPERIMENTAL
Intervention: Homework practices and adaptations used by general education teachers
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Differences in homework practices and adaptations across educational levels (elementary, middle, high school)
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Instructional implications of identified homework practices
Number of subjects: 441
Study: 2972597

Group type: EXPERIMENTAL
Intervention: Enoximone (0.5 mg/kg as a bolus)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dobutamine (5 micrograms/kg.min)
Number of subjects: 20
Study: 4461977

Group type: EXPERIMENTAL
Intervention: Massed Practice (MP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distributed Practice (DP)
Number of subjects: 60
Study: 31444535

Group type: EXPERIMENTAL
Intervention: Outpatient pelvic floor muscle training (PFMT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Home pelvic floor muscle training (PFMT)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Outpatient PFMT
Number of subjects: 69

Group type: COMPARATOR
Intervention: Home PFMT
Number of subjects: 69
Study: 30866669

Group type: EXPERIMENTAL
Intervention: Micronutrient Powder (MNP)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Bigas-Mongo (BigMo) complementary food blend
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Community health workers (CHWs) promotion of MNP and BigMo
Number of subjects: 130
Study: 28628969

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at DU20 acupoint with a frequency of 2‐10 Hz and intensity of 1‐5 mA
Number of subjects: 54

Group type: COMPARATOR
Intervention: Remifentanil 100 μg/kg/min
Number of subjects: 54
Study: 25133519

Group type: EXPERIMENTAL
Intervention: Active video game (AVG) for 60 minutes
Number of subjects: 24

Group type: COMPARATOR
Intervention: Seated rest (SR)
Number of subjects: 24
Study: 22712560

Group type: EXPERIMENTAL
Intervention: Ultrasound pre-treatment (1 MHz, 1 W/cm²)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ultrasound simultaneous treatment (1 MHz, 1 W/cm²)
Number of subjects: 0
Study: 21942857

Group type: EXPERIMENTAL
Intervention: Google Calendar
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard diary
Number of subjects: 12
Study: 18652325

Group type: EXPERIMENTAL
Intervention: Deeply needling Qiangji 4 points
Number of subjects: 279

Group type: COMPARATOR
Intervention: Routine acupuncture therapy
Number of subjects: 279
Study: 16998356

Group type: EXPERIMENTAL
Intervention: Primary repair buttressed with small intestinal submucosa (SIS), n = 51
Number of subjects: 108

Group type: COMPARATOR
Intervention: Primary repair (1 degrees), n = 57
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both groups (SIS and 1 degrees)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Patients with recurrent hernia
Number of subjects: 108
Study: 14580630

Group type: EXPERIMENTAL
Intervention: Practice‐individualized facilitation of implementation of tools and approaches
Number of subjects: 77
Study: 10945015

Group type: EXPERIMENTAL
Intervention: Dietary guidance plus ingestion of wheat bran biscuits (Regimen II)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Dietary guidance alone (Regimen I)
Number of subjects: 200
Study: 8980974

Group type: EXPERIMENTAL
Intervention: Training group (n = 32)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (n = 16)
Number of subjects: 48
Study: 1727835

Group type: EXPERIMENTAL
Intervention: Exercise group (n = 166): Low-to-moderate-intensity endurance training, 40 minutes thrice weekly on a cycle ergometer, with training heart rate set at 70% of peak heart rate.
Number of subjects: 247

Group type: COMPARATOR
Intervention: Attention control group (n = 81): Attended weekly group talks.
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Exercise group (n = 166): Low-to-moderate-intensity endurance training.
Number of subjects: 247
Study: 6747548

Group type: EXPERIMENTAL
Intervention: Memory condition (children instructed to memorize a subset of toys)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Play groups (control groups)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Memory condition
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Memory condition (oldest subjects)
Number of subjects: 180
Study: 30210024

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation with volume guarantee (PSV+VG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation (SIMV)
Number of subjects: 40
Study: 27289276

Group type: EXPERIMENTAL
Intervention: Hamstring tendon autograft
Number of subjects: 157

Group type: COMPARATOR
Intervention: Fresh-frozen allograft
Number of subjects: 157
Study: 24824900

Group type: EXPERIMENTAL
Intervention: Rehabilitative exercise training (RET)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard of care rehabilitation (SOC)
Number of subjects: 47
Study: 22918828

Group type: EXPERIMENTAL
Intervention: FDM-guided treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional manual therapy (MT)
Number of subjects: 60
Study: 20224951

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study: 18578221

Group type: EXPERIMENTAL
Intervention: Medication adherence interventions
Number of subjects: 63

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 63
Study: 15277626

Group type: EXPERIMENTAL
Intervention: Hypothermia (endovascular cooling device targeting 33 degrees C for 24 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard medical management (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hypothermia (in patients who cooled well)
Number of subjects: 40
Study: 11865386

Group type: EXPERIMENTAL
Intervention: 5 microg/kg clonidine
Number of subjects: 50

Group type: COMPARATOR
Intervention: 100 microg/kg midazolam
Number of subjects: 50
Study: 9822003

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg oral midazolam
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Parental presence during induction of anesthesia
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control (no parental presence or premedication)
Number of subjects: 88
Study: 8121459

Group type: EXPERIMENTAL
Intervention: c7E3 Fab bolus and infusion
Number of subjects: 2099

Group type: EXPERIMENTAL
Intervention: c7E3 Fab bolus alone
Number of subjects: 2099

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2099
Study: 2763031

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine and heparin (DHE/Hep)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 663049

Group type: EXPERIMENTAL
Intervention: Right ear feedback
Number of subjects: 20

Group type: COMPARATOR
Intervention: Left ear feedback
Number of subjects: 20
Study: 31136546

Group type: EXPERIMENTAL
Intervention: HIIE (80% V˙o2peak)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: AE-BFR (40% V˙o2peak)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: AE (40% V˙o2peak)
Number of subjects: 22

Group type: COMPARATOR
Intervention: CON (50% of BFR)
Number of subjects: 22
Study: 29437501

Group type: EXPERIMENTAL
Intervention: New technique for uvuloplasty (sacrificing one hemi-uvula and centralizing the remaining one)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional uvula repair (combining the 2 hemi-uvulae)
Number of subjects: 40
Study: 27434512

Group type: EXPERIMENTAL
Intervention: Robot-assisted group activity with Paro, 30 minutes twice a week for 12 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Robot-assisted group activity with Paro
Number of subjects: 53
Study: 24633297

Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (no umbilical cord milking)
Number of subjects: 44
Study: 23500269

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carvedilol (CRT-D subgroup)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carvedilol (CRT-D with LBBB subgroup)
Number of subjects: 0
Study: 20075055

Group type: EXPERIMENTAL
Intervention: High-level PS of 20 cmH(2)O (PS 20)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Unassisted exercise
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham PS
Number of subjects: 13

Group type: COMPARATOR
Intervention: Low-level PS of 10 cmH(2)O (PS 10)
Number of subjects: 13
Study: 18252756

Group type: EXPERIMENTAL
Intervention: Intervention schools (16 lessons on healthy eating, physical activity, and reducing TV viewing over 5 months)
Number of subjects: 679

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 679
Study: 15876467

Group type: EXPERIMENTAL
Intervention: pegylated interferon alpha‐2b (1.5 microg/kg) and ribavirin (400‐800 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no antiviral therapy)
Number of subjects: 24
Study: 12828103

Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (1g by continuous i.v. infusion starting 30 minutes before ERCP and continuing for 12 hours afterward)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (17 patients)
Number of subjects: 30
Study: 11063441

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (250 IU RRR‐alpha‐tocopherol 3 times/d for 1 year)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo for 6 months followed by Vitamin E supplementation (250 IU RRR‐alpha‐tocopherol 3 times/d for an additional 6 months)
Number of subjects: 44
Study: 9206238

Group type: EXPERIMENTAL
Intervention: Strengthening body resistance method
Number of subjects: 2

Group type: COMPARATOR
Intervention: Symptomatic treatment (Control)
Number of subjects: 2
Study: 1579221

Group type: EXPERIMENTAL
Intervention: Aspartame (40 mg/kg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sucrose-sweetened drink
Number of subjects: 10
Study: 6376482

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31475799

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 4018

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 4018
Study: 30064489

Group type: EXPERIMENTAL
Intervention: SODIS water treatment intervention
Number of subjects: 778

Group type: COMPARATOR
Intervention: Control group (usual drinking-water sources)
Number of subjects: 778
Study: 26658259

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 25526870

Group type: EXPERIMENTAL
Intervention: Text messages designed to reduce the frequency of binge drinking through the formation of specific action plans.
Number of subjects: 798

Group type: COMPARATOR
Intervention: Behaviourally neutral text messages intended to promote retention in the study.
Number of subjects: 798
Study: 22578105

Group type: EXPERIMENTAL
Intervention: Citicoline-enhanced beverage
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 20700794

Group type: EXPERIMENTAL
Intervention: Tafluprost (0.0015%)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Latanoprost (0.005%)
Number of subjects: 27
Study: 18945637

Group type: EXPERIMENTAL
Intervention: Levosimendan 1 mg once or twice daily
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Combined levosimendan groups
Number of subjects: 307

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307